Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
boston blog main
boston top stories
crispr
editas medicine
national top stories
biotech
boston
crispr therapeutics
gene editing
san francisco blog main
san francisco top stories
cancer
clinical trials
crispr-cas9
deals
drugs
feng zhang
intellia therapeutics
national
acquisitions
advanced therapies
agios therapeutics
allergan
atmp
avexis
base editing
bioprocess insider
bms
brammer bio
branden moriarty
bristol-myers squibb
broad institute
car-t
car-t chimeric antigen receptor
cas13
catalent
cell & gene
cell gene therapy
What
crispr
5
×
gene
5
×
editing
medicine
cas
editas
human
therapeutics
therapy
access
advanced
allergan
beam
bio
blessing
bosley
cancer
capacity
car
cell
cells
ceo
check
clinical
consolidation
create
cusp
defect
depart
diagnostic
diseases
drive
edited
editor
experimental
falcon
fears
fix
flag
focus
Language
unset
Current search:
gene
×
crispr
×
" life sciences "
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M